Evidence map›Paper›PMID 21161222›Full record

Trial reportWorld journal of surgery2011

Impact of low-dose vasopressin on trauma outcome: prospective randomized study.

Stephen M Cohn, Janet McCarthy, Ronald M Stewart, Rachelle B Jonas, Daniel L Dent, Joel E Michalek

2 registry-linked trialsOpen access · bronzeAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in World journal of surgery, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 34 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 6 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00420407 early_phase1terminatednot on this map

Prospective, Randomized, Double-Blind, Multi-Center Trial of Low Dose Vasopressin Versus Placebo in Traumatic Shock Resuscitation

TypeinterventionalSponsorThe University of Texas Health Science Center at San AntonioRan2007 to 2011Enrolled81ConditionsInjuries, Shock, TraumaticArmsnormal saline control, vasopressin
NCT06977659 phase1 / phase2enrolling by invitationnot on this mapstarted 2025, after this paper: background citation

Early Norepinephrine in Trauma Patients With Hemorrhagic Shock (ENTHeS Trial): A Randomized Open-label Clinical Trial

TypeinterventionalSponsorVisarat PalitnonkiatRan2025 to 2027Enrolled40ConditionsTrauma, MultipleArmsNorepinephrine, Placebo
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 6 syntheses or guidelines pooled it, 94 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Vasopressors for hypotensive shock.The Cochrane database of systematic reviews · 2016
    Pooled it
  6. Pooled it
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Rethinking Balanced Resuscitation in Trauma.Journal of clinical medicine · 2025
    Review
  12. Review
  13. Review
  14. Article
  15. Observational
  16. A Rationale for the Use of Norepinephrine after the Control of Bleeding in Hemorrhagic Shock?American journal of respiratory and critical care medicine · 2022
    Article
  17. Article
  18. Cerebral effects of resuscitation with either epinephrine or vasopressin in an animal model of hemorrhagic shock.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Stephen M CohnDepartment of Surgery, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA. cohn@uthscsa.edu
Janet McCarthy
Ronald M Stewart
Rachelle B Jonas
Daniel L Dent
Joel E Michalek
The University of Texas Health Science Center at San Antonio · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe previously found that regardless of the animal injury model used resuscitation strategies that minimize fluid administration requirements lead to better outcomes. We hypothesized that a resuscitation regimen that limited the total volume of fluid administered would reduce morbidity and mortality rates in critically ill trauma patients.

methodsWe performed a double-blind randomized trial to assess the safety and efficacy of adding vasopressin to resuscitative fluid. Subjects were hypotensive adults who had sustained acute traumatic injury. Subjects were given fluid alone (control group) or fluid plus vasopressin (experimental group), first as a bolus (4 IU) and then as an intravenous infusion of 200 ml/h (vasopressin 2.4 IU/h) for 5 h.

resultsWe randomly assigned 78 patients to the experimental group (n=38) or the control group (n=40). The groups were similar in age, sex, preexisting medical illnesses, and mechanism and severity of injury. Serum vasopressin concentrations were higher in the experimental group than in the control group at admission, after infusion of vasopressin (p=0.01), and 12 h later. The experimental group required a significantly lower total volume of resuscitation fluid over 5 days than did the control group (p=0.04). The mortality rate at 5 days was 13% in the experimental group and 25% in the control group (p=0.19). The rates of adverse events, organ dysfunction, and 30-day mortality were similar.

conclusionsThis is the first trial to investigate the impact of vasopressin administration in trauma patients. Infusion of low-dose vasopressin maintained elevated serum vasopressin levels and decreased fluid requirements after injury.

Indexed as

Fluid TherapyResuscitationDouble-Blind MethodFemaleHumansMaleMiddle AgedProspective StudiesVasoconstrictor AgentsVasopressinsWounds and InjuriesVasoconstrictor AgentsVasopressins

Identifiers

PMID21161222
OpenAlexW2013847400

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.